rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-7-15
|
pubmed:abstractText |
To evaluate the tolerance to vaccination against human papillomavirus (HPV)16 E7 (in SB adjuvant ASO2B) and its histological and immunohistological effects on HPV16 associated high-grade cervical dysplasias associated with HPV16.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0301-2115
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
109
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
219-23
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12860346-Adolescent,
pubmed-meshheading:12860346-Adult,
pubmed-meshheading:12860346-Antigens, CD1,
pubmed-meshheading:12860346-CD4-Positive T-Lymphocytes,
pubmed-meshheading:12860346-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12860346-Cervix Uteri,
pubmed-meshheading:12860346-Female,
pubmed-meshheading:12860346-Humans,
pubmed-meshheading:12860346-Middle Aged,
pubmed-meshheading:12860346-Oncogene Proteins, Viral,
pubmed-meshheading:12860346-Papillomaviridae,
pubmed-meshheading:12860346-Papillomavirus E7 Proteins,
pubmed-meshheading:12860346-Papillomavirus Infections,
pubmed-meshheading:12860346-Remission Induction,
pubmed-meshheading:12860346-Uterine Cervical Dysplasia,
pubmed-meshheading:12860346-Vaccination
|
pubmed:year |
2003
|
pubmed:articleTitle |
Cervical response to vaccination against HPV16 E7 in case of severe dysplasia.
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, CUB Hopital Erasme, Route de Lennik 808, 1070 Brussels, Belgium. psimon@ulb.ac.be
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|